- Home
- LPTH vs IMRX Comparison
LPTH vs IMRX Comparison
Compare LPTH & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- IMRX
- Stock Information
- Founded
- LPTH 1985
- IMRX 2008
- Country
- LPTH United States
- IMRX United States
- Employees
- LPTH N/A
- IMRX N/A
- Industry
- LPTH Semiconductors
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- LPTH Technology
- IMRX Health Care
- Exchange
- LPTH Nasdaq
- IMRX Nasdaq
- Market Cap
- LPTH 229.5M
- IMRX 232.9M
- IPO Year
- LPTH 1996
- IMRX 2021
- Fundamental
- Price
- LPTH $5.49
- IMRX $8.49
- Analyst Decision
- LPTH Strong Buy
- IMRX Strong Buy
- Analyst Count
- LPTH 3
- IMRX 4
- Target Price
- LPTH $5.33
- IMRX $13.00
- AVG Volume (30 Days)
- LPTH 1.4M
- IMRX 1.2M
- Earning Date
- LPTH 11-06-2025
- IMRX 08-13-2025
- Dividend Yield
- LPTH N/A
- IMRX N/A
- EPS Growth
- LPTH N/A
- IMRX N/A
- EPS
- LPTH N/A
- IMRX N/A
- Revenue
- LPTH $33,626,969.00
- IMRX N/A
- Revenue This Year
- LPTH $19.58
- IMRX N/A
- Revenue Next Year
- LPTH $44.50
- IMRX N/A
- P/E Ratio
- LPTH N/A
- IMRX N/A
- Revenue Growth
- LPTH 2.59
- IMRX N/A
- 52 Week Low
- LPTH $1.11
- IMRX $1.10
- 52 Week High
- LPTH $6.44
- IMRX $9.37
- Technical
- Relative Strength Index (RSI)
- LPTH 64.89
- IMRX 79.86
- Support Level
- LPTH $5.17
- IMRX $5.17
- Resistance Level
- LPTH $5.74
- IMRX $9.37
- Average True Range (ATR)
- LPTH 0.48
- IMRX 0.78
- MACD
- LPTH -0.00
- IMRX 0.31
- Stochastic Oscillator
- LPTH 57.96
- IMRX 81.16
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.